BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Alcohol Use Disorder readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Alcohol Use Disorder\
 , from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07219953-822@assetmemo.bio
DTSTAMP:20261121T004110Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:Brenipatide: Phase 3 readout est. (NCT07219953)
DESCRIPTION:Brenipatide\, phase 3\, Alcohol Use Disorder.\nStudy: A Study o
 f Brenipatide in Participants With Alcohol Use Disorder\nEstimated primary
  completion: April 2028. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/brenipatide#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07219953
URL:https://assetmemo.bio/drug/brenipatide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07219966-822@assetmemo.bio
DTSTAMP:20261121T004110Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:Brenipatide: Phase 3 readout est. (NCT07219966)
DESCRIPTION:Brenipatide\, phase 3\, Alcohol Use Disorder.\nStudy: A Study o
 f Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
 \nEstimated primary completion: April 2028. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/brenipatide#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07219966
URL:https://assetmemo.bio/drug/brenipatide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
